INVO Bioscience, Inc.

INVO Bioscience, Inc. (OTCQB: INVO) (“INVO”) is an innovative medical device company developing solutions for the global infertility industry. INVO’s goal to increase access to care and expand fertility treatment across the globe while seeking lower the cost of care and increase availability of care. INVO’s lead commercial product, the INVOcell, is a patented Assisted Reproductive Technology (ART) used in the treatment of infertility. The INVOcell device and procedure is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. Further, the INVOcell method offers an alternative to traditional in Vitro Fertilization (IVF) and Intrauterine Insemination (IUI), the revolutionary in vivo method of vaginal incubation. INVO Bioscience is headquartered in Sarasota, FL.